ATC Group: N01AB08 Sevoflurane

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N01AB08 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N01 Anesthetics
3 N01A Anesthetics, general
4 N01AB Halogenated hydrocarbons
5 N01AB08 Sevoflurane

Active ingredients in N01AB08

Active Ingredient Description
Sevoflurane

Sevoflurane is used as an inhalational anaesthetic for induction and maintenance of general anesthesia. As with all other inhalation agents sevoflurane depresses cardiovascular function in a dose related fashion. In patients with normal intracranial pressure (ICP), sevoflurane had minimal effect on ICP and preserved CO2 responsiveness.

Related product monographs

Title Information Source Document Type  
ULTANE Liquid for inhalation FDA, National Drug Code (US) MPI, US: SPL/Old

Medicines in this ATC group

United States (US)

Austria (AT)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.